This company has been marked as potentially delisted and may not be actively trading. TF Financial (THRD) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock THRD vs. OPK, ETNB, COLL, MLYS, HROW, SYRE, ZYME, GERN, RCUS, and NRIXShould you be buying TF Financial stock or one of its competitors? The main competitors of TF Financial include OPKO Health (OPK), 89bio (ETNB), Collegium Pharmaceutical (COLL), Mineralys Therapeutics (MLYS), Harrow (HROW), Spyre Therapeutics (SYRE), Zymeworks (ZYME), Geron (GERN), Arcus Biosciences (RCUS), and Nurix Therapeutics (NRIX). These companies are all part of the "pharmaceutical preparations" industry. TF Financial vs. OPKO Health 89bio Collegium Pharmaceutical Mineralys Therapeutics Harrow Spyre Therapeutics Zymeworks Geron Arcus Biosciences Nurix Therapeutics OPKO Health (NASDAQ:OPK) and TF Financial (NASDAQ:THRD) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership, community ranking, media sentiment and dividends. Do insiders and institutionals believe in OPK or THRD? 64.6% of OPKO Health shares are owned by institutional investors. Comparatively, 94.0% of TF Financial shares are owned by institutional investors. 49.7% of OPKO Health shares are owned by company insiders. Comparatively, 5.9% of TF Financial shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in OPK or THRD? OPKO Health received 452 more outperform votes than TF Financial when rated by MarketBeat users. Likewise, 65.69% of users gave OPKO Health an outperform vote while only 65.59% of users gave TF Financial an outperform vote. CompanyUnderperformOutperformOPKO HealthOutperform Votes51365.69% Underperform Votes26834.31% TF FinancialOutperform Votes6165.59% Underperform Votes3234.41% Do analysts rate OPK or THRD? OPKO Health currently has a consensus target price of $2.75, indicating a potential upside of 98.56%. TF Financial has a consensus target price of $9.33, indicating a potential upside of 80.53%. Given OPKO Health's stronger consensus rating and higher possible upside, equities research analysts plainly believe OPKO Health is more favorable than TF Financial.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OPKO Health 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75TF Financial 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more volatility & risk, OPK or THRD? OPKO Health has a beta of 1.42, suggesting that its share price is 42% more volatile than the S&P 500. Comparatively, TF Financial has a beta of 2.66, suggesting that its share price is 166% more volatile than the S&P 500. Which has higher valuation & earnings, OPK or THRD? TF Financial has lower revenue, but higher earnings than OPKO Health. OPKO Health is trading at a lower price-to-earnings ratio than TF Financial, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOPKO Health$689.36M1.35-$188.86M-$0.07-19.79TF FinancialN/AN/A-$30.82M-$0.62-8.34 Is OPK or THRD more profitable? TF Financial has a net margin of 0.00% compared to OPKO Health's net margin of -18.65%. TF Financial's return on equity of -9.31% beat OPKO Health's return on equity.Company Net Margins Return on Equity Return on Assets OPKO Health-18.65% -9.76% -6.46% TF Financial N/A -9.31%-9.03% Does the media favor OPK or THRD? In the previous week, OPKO Health had 14 more articles in the media than TF Financial. MarketBeat recorded 14 mentions for OPKO Health and 0 mentions for TF Financial. OPKO Health's average media sentiment score of 0.25 beat TF Financial's score of 0.00 indicating that OPKO Health is being referred to more favorably in the media. Company Overall Sentiment OPKO Health Neutral TF Financial Neutral SummaryOPKO Health beats TF Financial on 12 of the 17 factors compared between the two stocks. Get TF Financial News Delivered to You Automatically Sign up to receive the latest news and ratings for THRD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart THRD vs. The Competition Export to ExcelMetricTF FinancialPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$232.96M$6.85B$5.55B$8.03BDividend YieldN/A2.96%5.09%4.23%P/E Ratio-8.347.5022.7518.87Price / SalesN/A259.01405.65106.84Price / CashN/A65.8538.1834.62Price / Book0.786.566.794.34Net Income-$30.82M$143.63M$3.22B$248.06M TF Financial Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)THRDTF Financial1.5321 of 5 stars$5.17+0.2%$9.33+80.5%-55.5%$232.96MN/A-8.34N/AOPKOPKO Health4.4828 of 5 stars$1.37-3.5%$2.75+100.7%+6.5%$920.02M$713.14M-7.214,200Earnings ReportAnalyst ForecastAnalyst RevisionPositive NewsETNB89bio3.0503 of 5 stars$6.27+3.5%$27.25+334.6%-1.5%$915.32MN/A-2.1540Earnings ReportUpcoming EarningsAnalyst UpgradeAnalyst RevisionNews CoveragePositive NewsGap UpCOLLCollegium Pharmaceutical3.9808 of 5 stars$26.91-0.4%$43.60+62.0%-26.3%$864.67M$631.45M11.60210Upcoming EarningsNews CoverageMLYSMineralys Therapeutics2.4595 of 5 stars$13.24-0.8%$33.00+149.2%+17.8%$858.96MN/A-3.6428Upcoming EarningsShort Interest ↑News CoverageHROWHarrow2.2899 of 5 stars$23.24-3.1%$60.50+160.3%+142.8%$828.60M$199.61M-24.72182Positive NewsSYRESpyre Therapeutics1.9652 of 5 stars$13.57+7.1%$49.57+265.3%-58.3%$817.95M$890,000.00-1.82100Upcoming EarningsNews CoveragePositive NewsZYMEZymeworks2.8018 of 5 stars$11.75+1.9%$21.00+78.7%+44.0%$817.53M$76.30M-7.83460Upcoming EarningsAnalyst RevisionNews CoveragePositive NewsGERNGeron4.0188 of 5 stars$1.35+6.3%$5.75+325.9%-65.1%$808.88M$76.99M-4.2270Upcoming EarningsRCUSArcus Biosciences2.3894 of 5 stars$7.68-2.5%$30.25+293.9%-41.1%$807.46M$258M-2.44500Upcoming EarningsNews CoverageNRIXNurix Therapeutics2.1537 of 5 stars$10.55+3.0%$30.44+188.6%-11.5%$804.29M$56.42M-3.65300Analyst ForecastNews Coverage Related Companies and Tools Related Companies OPKO Health Competitors 89bio Competitors Collegium Pharmaceutical Competitors Mineralys Therapeutics Competitors Harrow Competitors Spyre Therapeutics Competitors Zymeworks Competitors Geron Competitors Arcus Biosciences Competitors Nurix Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:THRD) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TF Financial Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share TF Financial With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy THRD Stock Free THRD Stock Alerts